These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20233196)

  • 1. Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
    Lunnon MW; Wallace SM; Palmer JE; Francis-Lang A; Laurijssens BE; Mistry P; Albala B; Nagafuji T; Wilkinson IB; Maltby K
    Br J Clin Pharmacol; 2010 Mar; 69(3):252-61. PubMed ID: 20233196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography.
    Strachan FE; Newby DE; Sciberras DG; McCrea JB; Goldberg MR; Webb DJ
    Br J Clin Pharmacol; 2002 Oct; 54(4):386-94. PubMed ID: 12392586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.
    Dhaun N; Strachan FE; Newby DE; Johnston NR; Ford NF; Hammett JL; Palmisano M; Webb DJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):611-22. PubMed ID: 16305585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced endothelin-1 system activity with overweight and obesity.
    Weil BR; Westby CM; Van Guilder GP; Greiner JJ; Stauffer BL; DeSouza CA
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H689-95. PubMed ID: 21666117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the ATP-dependent potassium channel attenuates norepinephrine-induced vasoconstriction in the human forearm.
    Pickkers P; Jansen Van Rosendaal AJ; Van Der Hoeven JG; Smits P
    Shock; 2004 Oct; 22(4):320-5. PubMed ID: 15377886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
    Cockcroft JR; Clarke JG; Webb DJ
    Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.
    Stauffer BL; Westby CM; Greiner JJ; Van Guilder GP; Desouza CA
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R261-5. PubMed ID: 19939973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
    Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.
    Vaughan RB; Angus PW; Chin-Dusting JP
    Gut; 2003 Oct; 52(10):1505-10. PubMed ID: 12970146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men.
    Mori TA; Watts GF; Burke V; Hilme E; Puddey IB; Beilin LJ
    Circulation; 2000 Sep; 102(11):1264-9. PubMed ID: 10982541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
    Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
    Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
    Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans.
    Langrish JP; Lundbäck M; Mills NL; Johnston NR; Webb DJ; Sandström T; Blomberg A; Newby DE
    Hypertension; 2009 Oct; 54(4):910-5. PubMed ID: 19687345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearm.
    Rab A; Dallinger S; Polak K; Pleiner J; Polska E; Wolzt M; Schmetterer L
    J Pharmacol Exp Ther; 2004 May; 309(2):692-6. PubMed ID: 14757848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.